Selected research
Industry Research
PK/PD Modeling Industry Research Report 2026
Market perspective
The global PK/PD Modeling market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the PK/PD Modeling market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the PK/PD Modeling market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the PK/PD Modeling market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of PK/PD Modeling include Certara, Labcorp Drug Development, Comac Medical, Seda, Quanticate, Pipeline Biotech, PhInc. Modeling, Lilly Careers and BioPharma Services Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global PK/PD Modeling market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to PK/PD Modeling.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PK/PD Modeling Market by Company
Certara
Labcorp Drug Development
Comac Medical
Seda
Quanticate
Pipeline Biotech
PhInc. Modeling
Lilly Careers
BioPharma Services Inc.
Kaituo Pharmaceutical
Allucent
NorthEast BioLab
PK/PD Modeling Segment by Type
Direct Connection to PK/PD Model
Indirect Connection PK/PD Model
PK/PD Modeling Segment by Application
Drug Discovery
Clinical Trials
Market Assessment
Traditional Chinese Medicine Research
Clinical Medication Guidance
Model Pptimization and Technological Innovation
Others
PK/PD Modeling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PK/PD Modeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PK/PD Modeling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PK/PD Modeling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of PK/PD Modeling companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Direct Connection to PK/PD Model
- Indirect Connection PK/PD Model
Applications
- Drug Discovery
- Clinical Trials
- Market Assessment
- Traditional Chinese Medicine Research
- Clinical Medication Guidance
- Model Pptimization and Technological Innovation
- Others
Companies covered
- Certara
- Labcorp Drug Development
- Comac Medical
- Seda
- Quanticate
- Pipeline Biotech
- PhInc. Modeling
- Lilly Careers
- BioPharma Services Inc.
- Kaituo Pharmaceutical
- Allucent
- NorthEast BioLab
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 PK/PD Modeling by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Direct Connection to PK/PD Model
- 2.2.3 Indirect Connection PK/PD Model
- 2.3 PK/PD Modeling by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery
- 2.3.3 Clinical Trials
- 2.3.4 Market Assessment
- 2.3.5 Traditional Chinese Medicine Research
- 2.3.6 Clinical Medication Guidance
- 2.3.7 Model Pptimization and Technological Innovation
- 2.3.8 Others
- 2.4 Assumptions and Limitations
3 PK/PD Modeling Breakdown Data by Type
- 3.1 Global PK/PD Modeling Historic Market Size by Type (2021-2026)
- 3.2 Global PK/PD Modeling Forecasted Market Size by Type (2027-2032)
4 PK/PD Modeling Breakdown Data by Application
- 4.1 Global PK/PD Modeling Historic Market Size by Application (2021-2026)
- 4.2 Global PK/PD Modeling Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global PK/PD Modeling Market Perspective (2021-2032)
- 5.2 Global PK/PD Modeling Growth Trends by Region
- 5.2.1 Global PK/PD Modeling Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 PK/PD Modeling Historic Market Size by Region (2021-2026)
- 5.2.3 PK/PD Modeling Forecasted Market Size by Region (2027-2032)
- 5.3 PK/PD Modeling Market Dynamics
- 5.3.1 PK/PD Modeling Industry Trends
- 5.3.2 PK/PD Modeling Market Drivers
- 5.3.3 PK/PD Modeling Market Challenges
- 5.3.4 PK/PD Modeling Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top PK/PD Modeling Players by Revenue
- 6.1.1 Global Top PK/PD Modeling Players by Revenue (2021-2026)
- 6.1.2 Global PK/PD Modeling Revenue Market Share by Players (2021-2026)
- 6.2 Global PK/PD Modeling Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of PK/PD Modeling Head Office and Area Served
- 6.4 Global PK/PD Modeling Players, Product Type & Application
- 6.5 Global PK/PD Modeling Manufacturers Established Date
- 6.6 Global PK/PD Modeling Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America PK/PD Modeling Market Size (2021-2032)
- 7.2 North America PK/PD Modeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America PK/PD Modeling Market Size by Country (2021-2026)
- 7.4 North America PK/PD Modeling Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe PK/PD Modeling Market Size (2021-2032)
- 8.2 Europe PK/PD Modeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe PK/PD Modeling Market Size by Country (2021-2026)
- 8.4 Europe PK/PD Modeling Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific PK/PD Modeling Market Size (2021-2032)
- 9.2 Asia-Pacific PK/PD Modeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific PK/PD Modeling Market Size by Country (2021-2026)
- 9.4 Asia-Pacific PK/PD Modeling Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America PK/PD Modeling Market Size (2021-2032)
- 10.2 South America PK/PD Modeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America PK/PD Modeling Market Size by Country (2021-2026)
- 10.4 South America PK/PD Modeling Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa PK/PD Modeling Market Size (2021-2032)
- 11.2 Middle East & Africa PK/PD Modeling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa PK/PD Modeling Market Size by Country (2021-2026)
- 11.4 Middle East & Africa PK/PD Modeling Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Certara
- 12.1.1 Certara Company Information
- 12.1.2 Certara Business Overview
- 12.1.3 Certara Revenue in PK/PD Modeling Business (2021-2026)
- 12.1.4 Certara PK/PD Modeling Product Portfolio
- 12.1.5 Certara Recent Developments
- 12.2 Labcorp Drug Development
- 12.2.1 Labcorp Drug Development Company Information
- 12.2.2 Labcorp Drug Development Business Overview
- 12.2.3 Labcorp Drug Development Revenue in PK/PD Modeling Business (2021-2026)
- 12.2.4 Labcorp Drug Development PK/PD Modeling Product Portfolio
- 12.2.5 Labcorp Drug Development Recent Developments
- 12.3 Comac Medical
- 12.3.1 Comac Medical Company Information
- 12.3.2 Comac Medical Business Overview
- 12.3.3 Comac Medical Revenue in PK/PD Modeling Business (2021-2026)
- 12.3.4 Comac Medical PK/PD Modeling Product Portfolio
- 12.3.5 Comac Medical Recent Developments
- 12.4 Seda
- 12.4.1 Seda Company Information
- 12.4.2 Seda Business Overview
- 12.4.3 Seda Revenue in PK/PD Modeling Business (2021-2026)
- 12.4.4 Seda PK/PD Modeling Product Portfolio
- 12.4.5 Seda Recent Developments
- 12.5 Quanticate
- 12.5.1 Quanticate Company Information
- 12.5.2 Quanticate Business Overview
- 12.5.3 Quanticate Revenue in PK/PD Modeling Business (2021-2026)
- 12.5.4 Quanticate PK/PD Modeling Product Portfolio
- 12.5.5 Quanticate Recent Developments
- 12.6 Pipeline Biotech
- 12.6.1 Pipeline Biotech Company Information
- 12.6.2 Pipeline Biotech Business Overview
- 12.6.3 Pipeline Biotech Revenue in PK/PD Modeling Business (2021-2026)
- 12.6.4 Pipeline Biotech PK/PD Modeling Product Portfolio
- 12.6.5 Pipeline Biotech Recent Developments
- 12.7 PhInc. Modeling
- 12.7.1 PhInc. Modeling Company Information
- 12.7.2 PhInc. Modeling Business Overview
- 12.7.3 PhInc. Modeling Revenue in PK/PD Modeling Business (2021-2026)
- 12.7.4 PhInc. Modeling PK/PD Modeling Product Portfolio
- 12.7.5 PhInc. Modeling Recent Developments
- 12.8 Lilly Careers
- 12.8.1 Lilly Careers Company Information
- 12.8.2 Lilly Careers Business Overview
- 12.8.3 Lilly Careers Revenue in PK/PD Modeling Business (2021-2026)
- 12.8.4 Lilly Careers PK/PD Modeling Product Portfolio
- 12.8.5 Lilly Careers Recent Developments
- 12.9 BioPharma Services Inc.
- 12.9.1 BioPharma Services Inc. Company Information
- 12.9.2 BioPharma Services Inc. Business Overview
- 12.9.3 BioPharma Services Inc. Revenue in PK/PD Modeling Business (2021-2026)
- 12.9.4 BioPharma Services Inc. PK/PD Modeling Product Portfolio
- 12.9.5 BioPharma Services Inc. Recent Developments
- 12.10 Kaituo Pharmaceutical
- 12.10.1 Kaituo Pharmaceutical Company Information
- 12.10.2 Kaituo Pharmaceutical Business Overview
- 12.10.3 Kaituo Pharmaceutical Revenue in PK/PD Modeling Business (2021-2026)
- 12.10.4 Kaituo Pharmaceutical PK/PD Modeling Product Portfolio
- 12.10.5 Kaituo Pharmaceutical Recent Developments
- 12.11 Allucent
- 12.11.1 Allucent Company Information
- 12.11.2 Allucent Business Overview
- 12.11.3 Allucent Revenue in PK/PD Modeling Business (2021-2026)
- 12.11.4 Allucent PK/PD Modeling Product Portfolio
- 12.11.5 Allucent Recent Developments
- 12.12 NorthEast BioLab
- 12.12.1 NorthEast BioLab Company Information
- 12.12.2 NorthEast BioLab Business Overview
- 12.12.3 NorthEast BioLab Revenue in PK/PD Modeling Business (2021-2026)
- 12.12.4 NorthEast BioLab PK/PD Modeling Product Portfolio
- 12.12.5 NorthEast BioLab Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst